The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2024

Filed:

May. 09, 2019
Applicant:

Helixmith Co., Ltd., Seoul, KR;

Inventors:

Miwon Son, Gyeonggi-do, KR;

Doo Suk Lee, Gyeonggi-do, KR;

Sunyoung Kim, Seoul, KR;

In-Jeong Nam, Seoul, KR;

Assignee:

HELIXMITH CO., LTD., Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/53 (2006.01); A23L 33/105 (2016.01); A61K 31/445 (2006.01); A61K 36/77 (2006.01); A61K 36/8965 (2006.01); A61K 36/8988 (2006.01); A61P 25/00 (2006.01);
U.S. Cl.
CPC ...
A61K 36/53 (2013.01); A23L 33/105 (2016.08); A61K 31/445 (2013.01); A61K 36/77 (2013.01); A61K 36/8965 (2013.01); A61K 36/8988 (2013.01); A61P 25/00 (2018.01); A61K 2236/331 (2013.01); A61K 2236/333 (2013.01);
Abstract

Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.


Find Patent Forward Citations

Loading…